Fluticasone Furoate-Vilanterol Decreases COPD Exacerbations in a Pragmatic Trial

This study demonstrates that fluticasone furoate-vilanterol reduces Chronic Obstructive Pulmonary Disease exacerbations compared with usual care when studied in a real-world primary care setting. Source: Vestbo J, Leather D, Bakerly ND, New J et al. Effectiveness of fluticasone furoate-vilanterol for COPD in clinical practice. N Engl J Med. 2016.
Source: Clinical Pulmonary Medicine - Category: Respiratory Medicine Tags: Pulmonary Trends Source Type: research